eNOS genetic polymorphisms and cancer risk: Evidence from a meta-analysis and a case-control study of breast cancer

Date

19 Dec 2015

Session

Poster presentation 1

Presenters

Xueren Gao

Citation

Annals of Oncology (2015) 26 (suppl_9): 8-15. 10.1093/annonc/mdv518

Authors

X. Gao1, J. Wang1, W. Wang1, M. Wang2, J. Zhang1

Author affiliations

  • 1 Key Laboratory Of Developmental Genes And Human Disease, Ministry Of Education; Department Of Microbiology And Immunology, Medical School of Southeast University, 210009 - Nanjing/CN
  • 2 Department Of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu/CN
More

Resources

Aim/Background

The association between endothelial nitric oxide synthase (eNOS) polymorphisms (intron 4a/b, -786T > C and 894G > T) and cancer risk remains elusive. In addition, no studies focused on their associations with risk of breast cancer in Chinese Han population. Thus, a meta-analysis was conducted to determine the relationship between eNOS polymorphisms and cancer risk, and then a case-control study in Chinese Han population was performed to assess their associations with breast cancer susceptibility.

Methods

Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association.

Results

The pooled analysis indicated that eNOS intron 4a/b and -786T > C polymorphisms were significantly associated with an increased risk of overall cancer. In subgroup analyses based on cancer type, the significant association was found between eNOS intron 4a/b polymorphism and prostate cancer risk, between eNOS -786T > C polymorphism and risk of prostate, bladder and breast cancers, and between eNOS 894G > T polymorphism and breast cancer risk. In subgroup analyses based on ethnicity, eNOS intron 4a/b and -786T > C polymorphisms were associated with an increased risk of cancer in Caucasians. In consistent with our meta-analysis results, a case-control study in Chinese Han population showed significant associations of eNOS -786T > C and 894G > T polymorphisms with the increased risk of breast cancer. In addition, stratified analyses based on pathological type showed that eNOS 894G > T polymorphism was only associated with risk of infiltrative ductal carcinoma. Stratified analyses by tumor stage showed that eNOS -786T > C polymorphism was only associated with the risk of tumor stage III and IV.

Conclusions

Our meta-analysis and case-control study suggest that eNOS -786T > C and 894G > T polymorphisms are associated with the increased risk of breast cancer.

Clinical trial identification

Disclosure

All authors have declared no conflicts of interest.

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings